000 01283 a2200337 4500
005 20250515103046.0
264 0 _c20080521
008 200805s 0 0 fre d
022 _a0929-693X
024 7 _a10.1016/j.arcped.2007.09.013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMellouli, F
245 0 0 _a[The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].
_h[electronic resource]
260 _bArchives de pediatrie : organe officiel de la Societe francaise de pediatrie
_cJan 2008
300 _a24-8 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article
650 0 4 _aAnemia, Sickle Cell
_xdrug therapy
650 0 4 _aChild
650 0 4 _aHeterozygote
650 0 4 _aHomozygote
650 0 4 _aHospitalization
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aHydroxyurea
_xtherapeutic use
650 0 4 _aLength of Stay
650 0 4 _aProspective Studies
650 0 4 _aThalassemia
_xclassification
650 0 4 _aTunisia
700 1 _aBejaoui, M
773 0 _tArchives de pediatrie : organe officiel de la Societe francaise de pediatrie
_gvol. 15
_gno. 1
_gp. 24-8
856 4 0 _uhttps://doi.org/10.1016/j.arcped.2007.09.013
_zAvailable from publisher's website
999 _c17675925
_d17675925